140 related articles for article (PubMed ID: 27532121)
1. [Prostate cancer screening].
Rodríguez-Carlin A; Castillo O
Medwave; 2016 Jul; 16(6):e6504. PubMed ID: 27532121
[No Abstract] [Full Text] [Related]
2. Prostate-specific antigen, prostate cancer screening, and the pathologist: what should be our role?
Jackson BR
Arch Pathol Lab Med; 2013 Mar; 137(3):308-9. PubMed ID: 22799565
[No Abstract] [Full Text] [Related]
3. Early detection of prostate cancer: can we have our cake and eat it too?
Masterson TA; Cary C; Cheng L
Expert Rev Anticancer Ther; 2016; 16(3):247-9. PubMed ID: 26760708
[No Abstract] [Full Text] [Related]
4. Early detection of prostate cancer.
Taneja SS
Urol Clin North Am; 2014 May; 41(2):xi-xii. PubMed ID: 24725495
[No Abstract] [Full Text] [Related]
5. Alternative prostate cancer screening strategies.
Labrecque M; Aprikian A
Ann Intern Med; 2013 May; 158(10):778. PubMed ID: 23689773
[No Abstract] [Full Text] [Related]
6. Alternative prostate cancer screening strategies--in response.
Gulati R; Etzioni R
Ann Intern Med; 2013 May; 158(10):778-9. PubMed ID: 23689774
[No Abstract] [Full Text] [Related]
7. Laurence Klotz on the Controversy Surrounding Screening for Prostate Cancer.
Klotz L
Oncology (Williston Park); 2016 Aug; 30(8):694, 764. PubMed ID: 27528237
[No Abstract] [Full Text] [Related]
8. Prostate cancer screening.
Eastham J
Investig Clin Urol; 2017 Jul; 58(4):217-219. PubMed ID: 28681029
[No Abstract] [Full Text] [Related]
9. Probability, uncertainty, and prostate cancer.
Concato J
Ann Intern Med; 2013 Feb; 158(3):211-212. PubMed ID: 23381041
[No Abstract] [Full Text] [Related]
10. Summaries for patients. Screening smarter, not harder, for prostate cancer.
Ann Intern Med; 2013 Feb; 158(3):I-30. PubMed ID: 23381056
[No Abstract] [Full Text] [Related]
11. [Does a low PSA at 60 years old exclude the risk of developing prostate carcinoma?].
Zürcher S
Rev Med Suisse; 2014 Jun; 10(434):1316. PubMed ID: 25073308
[No Abstract] [Full Text] [Related]
12. Mass screening of prostate cancer in Vietnam: current status and our opinions.
Vu Le C; Dao OQ; Khac Tran LN
Urol Oncol; 2010; 28(6):673-6. PubMed ID: 21062650
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer screening and mortality: comparison of recent randomized controlled clinical trials.
Mian BM
Urol Oncol; 2010; 28(3):233-6. PubMed ID: 20097584
[No Abstract] [Full Text] [Related]
14. Screening for prostate cancer starting at age 50-54 years.
Joob B; Wiwanitkit V
J Cancer Res Ther; 2019 Mar; 15(Supplement):S177. PubMed ID: 30900644
[No Abstract] [Full Text] [Related]
15. Prostate cancer screening "reloaded".
Gomella LG
Can J Urol; 2010 Apr; 17(2):5057. PubMed ID: 20398441
[No Abstract] [Full Text] [Related]
16. Is prostate cancer screening responsible for the negative results of prostate cancer treatment trials?
Prasad V
Med Hypotheses; 2016 Aug; 93():71-3. PubMed ID: 27372859
[TBL] [Abstract][Full Text] [Related]
17. Editorial for "Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50".
Andriole GL; Kibel AS
Cancer; 2011 Mar; 117(6):1110-2. PubMed ID: 20960524
[No Abstract] [Full Text] [Related]
18. Prostate cancer: updates on current strategies for screening, diagnosis and clinical implications of treatment modalities.
Tian JY; Guo FJ; Zheng GY; Ahmad A
Carcinogenesis; 2018 Mar; 39(3):307-317. PubMed ID: 29216344
[TBL] [Abstract][Full Text] [Related]
19. Prostate Cancer Screening and the Associated Controversy.
Tabayoyong W; Abouassaly R
Surg Clin North Am; 2015 Oct; 95(5):1023-39. PubMed ID: 26315521
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer screening.
Sikaris K
Pathology; 2012 Feb; 44(2):99-109. PubMed ID: 22198258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
